Peptide YY and cancer: Current findings and potential clinical applications

Peptides

Volumn 23, Issue 2, 2002, Pages 389-395

  Tseng, William W ^a   Liu, Carson D ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Cachexia; Cancer; Carcinogenesis; Carcinoid tumor; Cell growth; Malnutrition; Peptide YY; Synthetic analogues; Tissue expression

Indexed keywords

CYCLIC AMP; PEPTIDE YY;

ADVANCED CANCER; ARTICLE; BREAST TUMOR; CACHEXIA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; COLON ADENOCARCINOMA; DIGESTIVE SYSTEM CANCER; DRUG MECHANISM; HUMAN; IATROGENIC DISEASE; MALNUTRITION; NONHUMAN; OVARY CARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; BREAST NEOPLASMS; CACHEXIA; CARCINOID TUMOR; CELL DIVISION; COLONIC NEOPLASMS; CYCLIC AMP; HUMANS; PANCREATIC NEOPLASMS; PEPTIDE YY; TIME FACTORS;

EID: 0036159620     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00616-7     Document Type: Article

References (52)

1. Lack of peptide YY immunoreactivity in adenomatous colonic polyps: Evidence in favor of an adenoma-carcinoma sequence
2. Human distribution and release of a putative new gut hormone, peptide YY
3. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: Development of analogues with potent in vivo activity in the intestine
4. Peptide YY augments postprandial small intestinal absorption in the conscious dog
5. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29
6. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy
7. Distribution of PYY receptors in human fat cells: An antilipolytic system alongside the alpha 2-adrenergic system
8. Neuropeptide Y family of peptides: Structure, anatomical expression, function, and molecular evolution
9. Preservation of intestine protein by peptide YY during total parenteral nutrition
10. Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrition and treated with peptide YY and clenbuterol
11. Colonic endocrine cells in patients with carcinoma of the colon
12. How age changes the content of neuroendocrine peptides in the murine gastrointestinal tract
13. Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro
14. Glucagon, glicentin, proglucagon PYY, PP, and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors, and related non-tumor cells
15. Growth hormone upregulates gastrin and peptide YY gene expression
16. Intestinal peptide YY: Ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel
17. Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium?
18. Is peptide YY trophic to the intestinal epithelium of parenterally fed rats?
19. Peptide YY inhibits growth of human breast cancer in vitro, and in vivo
20. Effects of peptide YY on the growth of the pancreas and intestine
21. Immunohistochemical analysis of gastrointestinal carcinoids
22. The pancreatic polypeptide (PP-fold) family: Gastrointestinal, vascular, and feeding behavioral implications
23. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth
24. Peptide YY, and vitamin E inhibit hormone-sensitive, and -insensitive breast cancer cells
25. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia
26. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
27. Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats
28. Immunohistochemical and ultrastructural studies of twelve argentaffin and six argyrophil carcinoids of the appendix vermiformis
29. Peptide YY immunoreactive cells in gastrointestinal carcinoids: Immunohistochemical, and ultrastructural studies of 60 tumors
30. Neuroendocrine cells within colorectal tumours induced by dimethylhydrazine. An immunocytochemical study
31. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: Comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice
32. B-cell leukemia protein-2, and peptide YY chemotherapy resistance in colon cancer
33. Stimulatory actions of insulin-like growth factor-I and transforming growth factor-α on intestinal neurotensin and peptide YY
34. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1
35. Intraluminal peptide YY induces colonic absorption in vivo
36. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth
37. Y2 receptors decrease human pancreatic cancer growth, and intracellular cyclic adenosine monophosphate levels
38. Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium, and mucosal nerves of the human colon
39. Nutrition in cancer patients
40. Peptide YY (PYY), a potent orexigenic agent
41. Functioning ovarian carcinoids induce severe constipation
42. Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets
43. Effects of keratinocyte growth factor (KGF) on gut growth and repair
44. Neuropeptide Y, and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells
45. Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice
46. Peptide YY selectively stimulates expression of the colonocytic phenotype
47. Ovarian strumal carcinoid with severe constipation: Immunohistochemical and mRNA analyses of peptide YY
48. Peptide YY-like immunoreactivity in normal colon mucosa, muscle layer, and adenocarcinoma
49. Role of peptide YY in the endocrine control of digestion
50. Polypeptide YY (PYY), and pancreatic polypeptide (PP) in rectal carcinoids. An immunocytochemical study
51. Ovarian carcinoid with severe constipation due to peptide YY production